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ABSTRACT
Background: Osteochondral knee failures are among the most common causes of disability among the elderly human 
population and animal athletes. The xenogeneic transplantation of mesenchymal stem cells is a questionable therapeutic 
alternative that, despite the low expression of Major Histocompatibility Complex type II by these cells, still has relevant 
uncertainties about the safety and clinical efficacy. The main objective of the present study was to investigate whether 
the xenogeneic transplantation of mesenchymal stem cells induces hyaline cartilage formation, without histopathological 
evidence of rejection, in osteochondral failures of goats.
Materials, Methods & Results: Five female goats were used, submitted to three surgical osteocondral failures in the right 
knee, treated with xenogenic mesenchymal stem cells of dental pulp, xenogenic platelet-rich plasma and hemostatic sponge 
of hydrolyzed collagen, respectively. The lesions were evaluated after 60 days of treatment, aiming to identify the presence 
of hyaline cartilage or fibrocartilage and the subchondral bone pattern (regenerated or disorganized). Transplantation of 
xenogenic mesenchymal stem cells induced predominant formation of hyaline cartilage (P < 0.05), with no histopathologi-
cal evidence of inflammation when compared to the other treatments. Therapies with xenogeneic platelet-rich plasma and 
hemostatic sponge of hydrolyzed collagen induced greater formation of fibrocartilaginous cartilage, with no significant 
difference between them (P > 0.05). Macroscopically, the lesions of the stem cell treated group showed formation of firm 
repair tissue, opaque staining, integrated with adjacent cartilage and with the failure filling almost completely. The groups 
treated with PRP and hemostatic sponge of hydrolyzed collagen presented, on average, partial filling of the lesion, with 
irregular shape and darkened coloration.
Discussion: The absence of macroscopic and histopathological evidences of an inflammatory process on the surface and 
in the internal portion of the osteochondral lesions treated with xenogeneic stem cells, probably due to the low expression 
of Major Histocompatibility Complex type II by these cells, which would theoretically induce low rejection response. 
Such observations are of great importance, since graft-versus-host disease syndrome is a serious condition, responsible 
for the low therapeutic efficacy with transplantation of cells or grafts in humans. The formation of fibrocartilage, although 
without macro and microscopic evidence of degeneration or necrosis, in the osteochondral failures treated with PRP and 
hemostatic collagen sponge suggest that paracrine factors of the local microenvironment of the osteochondral failure are 
possibly responsible for the formation of fibrocartilaginous tissue or by inhibition of normal cartilage formation. The 
fibrocartilage formed in the Plasma and Control groups, contributed to the commitment in the filling of the lesion, con-
trasting with the almost complete fill of the lesions treated with stem cells. The xenotransplantation of mesenchymal stem 
cells induced formation of hyaline cartilage and did not promote histopathological evidence of rejection in osteochondral 
lesions of goat knees. The treatments with PRP and hemostatic sponge of hydrolyzed collagen induced greater formation 
of fibrocartilaginous cartilaginous surface in the osteochondral failures.
Keywords: mesenchymal stem cells, hyaline cartilage, goat.
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INTRODUCTION
Along the last decade, the use of mesenchymal 
stem cells for the purpose of bone and joint regenera-
tion was intensively investigated [24,31]. In addition to 
the bone marrow, adipose tissue and dental pulp have 
been used as source of collection [14,26], and high in 
vitro plasticity of these cells have been demonstrated 
in mesodermal and non-mesodermal tissues [20,27].
Xenogeneic stem cell transplantation for treat-
ment of osteochondral lesions is a therapeutic alterna-
tive that still has relevant uncertainties about clinical 
safety and efficacy [26]. However, a recent study has 
demonstrated the effective contribution of this alterna-
tive in murine model [18].
Biodegradable materials such as hemostatic 
collagen sponges have been used as scaffolds for repair 
of bone failures, especially in human dentistry [16], 
but its effectiveness as a carrier for mesenchymal stem 
cells is unknown. 
In addition, platelet-rich plasma is a potent 
osteoinducer, rich in growth factors capable to increase 
mitotic activity, activate fibroblasts, inducing angio-
genesis, and other features [3,19,21].
The objective of this study was to investigate 
the effect of xenogenic transplantation of mesenchy-
mal stem cells on the formation of hyaline cartilage, 
compared to treatments with xenogenic platelet-rich 
plasma and hemostatic collagen sponge, in osteochon-
dral failures of goats.
MATERIALS AND METHODS
Animals
Two animals were exclusively used as donors 
of stem cells and blood plasma and five animals to com-
pose the experimental groups of the preclinical study.
One male agouti (Dasyprocta primnolopha) 
was used as stem cells donor and one adult equine, 
with hematimetric values within the standard of nor-
mality for the species [10] and a total platelet count 
of 200 x 103/mm3 or greater was used as a donor of 
blood plasma.
For the preclinical study, five native female 
goats (Capra hircus), clinically healthy, non-breed, 
pluriparous, non-pregnant, three years old and average 
weight of 35.5 ± 1.5 kg were used. The goats were fed 
with commercial food¹ for the species, in addition to 
voluminous at will with supply of forage brachiaria 
grass and leguminous leucena, mineral salt and water 
ad libitum.
Obtaining of mesenchymal stem cells
Mesenchymal stem cells (MSC) were previ-
ously isolated from the dental pulp of an agouti [8]. 
The dental pulp of a lower incisor tooth was washed 
in sterile saline phosphate buffer solution (PBS2) 
0.01 M pH 7.4, supplemented with 3% penicillin-
streptomycin³ and mechanically dissociated into the 
Dulbecco’s Modified Eagle’s (F12 DMEM)4 culture 
medium, supplemented with 20% fetal bovine serum³, 
1% penicillin-streptomycin³, L-glutamine³ and non-
essential amino acids³. The material was incubated at 
5% CO2 and 37ºC and the cells cultured and expanded 
until the fourth passage. Cells were characterized by 
analyzing the expression of the CD34, CD14, CD45, 
CD73, CD79, CD90 and CD105 markers. Subsequent-
ly, mesenchymal stem cells were cryopreserved in a 
medium consisting of 45% F12 DMEM4 supplemented 
with 45% fetal bovine serum³ and 10% dimethyl sulf-
oxide5. Cells remained cryopreserved for two years 
until thawed in 37ºC water bath, viability was assessed 
by the trypan blue method and expanded until they 
reached 80% confluency. 
Interaction assay between stem cells and hemostatic 
sponge
Three aliquots of 1 x 104 cells/mL were cul-
tured with a 3 x 1 mm sample of a sterile hemostatic 
sponge of hydrolyzed collagen6 until they reached 
80% confluence. The culture wells were evaluated 
and photographed to evaluate the interaction between 
cells and hemostatic sponge. Subsequently, the sponge 
fragment was removed and the mesenchymal stem 
cells were trypsinized and evaluated for cell viability 
[8]. The fragments of the hemostatic sponge were 
fixed in 5% formaldehyde7 alone for 24 h, dehydrated 
in increasing concentrations of alcohol7 (30%, 55%, 
70%, 88%, 96%), diaphanized in xylol8, included in 
histological paraffin9 and sectioned with a rotary mi-
crotome10, adjusted to 4 μm thick. Slices were fixed 
in glass slide, stained by Hematoxylin & Eosin and 
analyzed by binocular optical microscope11 for evalu-
ation of cell adhesion.
Obtaining of platelet-rich plasma
The blood was immediately processed accord-
ing to the methodology described [3]. The concentra-
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tion of whole blood platelets was measured, followed 
by centrifugation of the sample at 600 g for five min. 
For each 25 μL of platelet-rich plasma obtained, 25 μL 
of 10% calcium gluconate was added, kept in a water 
bath at 37°C until the plasma was gelled.
Induction of osteochondral lesions in goats
All animals were submitted to antibiotic therapy 
with enrofloxacin12 (2.5 mg/kg) by intramuscular route 
and 2 h of water fasting and feeding of 6 h. The animals 
were sedated with intramuscular 2% xylazine13 (0.1 
mg/kg), induced with intravenous propofol14 (5 mg/kg) 
and spinal anesthesia were performed with morphine14 
(0.1 mg/kg) associated to 0.5% isobaric bupivacaine14 
in the volume of 0.2 mL, followed by intubation and 
anesthetic maintenance with Isoflurane14 diluted in 100% 
oxygen. The surgical field was delimited on the right 
femur-tibial-patellar joint. An arthrotomy of the medial 
parapatellar region was performed, the subcutaneous 
tissue was incised to access the patella, which was lat-
erally displaced by manual compression to expose the 
femoral trochlea. With the aid of an orthopedic drill15 
equipped with a 4 mm steel drill16, three osteochondral 
lesions 4 mm in diameter and 6 mm deep were pro-
duced, two in the distal part of the femoral trochlea and 
one in the proximal part. After immediate treatment of 
osteochondral failure, the joint capsule were closed with 
single interrupted suture with 2-0 nylon monofilament 
yarn17. Surgical plans were approximated with Sultan 
interrupted suture plane and skin with single interrupted 
suture, both using 2-0 nylon monofilamentar yarn17.
After the surgery, the animals were medicated 
with tramadol hydrochloride18 (2 mg/kg) by intramus-
cular route twice daily for five days, enrofloxacin12 (2.5 
mg/kg) by subcutaneous route once daily for 10 days 
and meloxicam19 (0.2 mg/kg) by intramuscular route 
once daily for 5 days. Surgical wounds were cleaned 
daily with sterile saline solution and topical application 
of allantoin and chlorhexidine ointment20.
Treatments
Each lesion represents an experimental group 
of treatment, coexisting all groups in each animal, 
totaling 15 lesions and 5 replicates for each treatment. 
The animals were treated once in the trans operative, 
according to the experimental groups: Control group: 
distal left lesion of the trochlea, treated with filling 
of the osteochondral failure with 3 mm of sterile 
hemostatic sponge of hydrolyzed collagen soaked in 
sterile physiological solution. MSC group: proximal 
inferior lesion of the trochlea, treated with 106 MSC/
mL infused into 3 mm of sterile hemostatic sponge 
of hydrolyzed collagen. Platelet Rich Plasma (PRP) 
group: distal right lesion of the trochlea, treated with 
platelet rich plasma at a concentration of 1.3 x 106/mm3 
infused in 3 mm of hemostatic sponge. 
Histological procedure
After 60 days of treatment, the animals were 
identified, weighed and submitted to euthanasia by se-
dation with ketamine20 (30 mg/kg) given intravenously 
and after confirmation of unconsciousness, administra-
tion of potassium chloride21 by intravenous route. The 
lesions were identified, serrated and fixed individually 
in 10% formaldehyde7 buffered for 48 h. The samples 
were decalcified in 20% hydrochloric acid solution for 
ten days and 5% for five days. The decalcified frag-
ments were processed histologically in a conventional 
manner [24]. The samples were included in histological 
paraffin9, sectioned with a rotary microtome10, adjusted 
to 5 μm thick. Slices were fixed in glass slide, stained 
by Hematoxylin & Eosin and analyzed in binocular 
optical microscope11.
Microscopic evaluation
For each osteochondral lesion, the scores 
were assigned: 0-absence of tissue covering the le-
sion, 1-formation of fibrocartilage and 2-formation of 
hyaline cartilage.
Statistical analysis
Statistical analysis was performed with Bioes-
tat® software v. 5.9, applying the Kruskal-Wallis non-
parametric analysis of independent samples, followed 
by the Dunn station median comparison test, adopting a 
level of rejection of the null hypothesis of 5% (P ≤ 0.05).
RESULTS
Goats remained clinically healthy after induc-
tion of osteochondral lesions, without clinical evidence 
of anorexia, fever and/or apathy. It was identified 
evident claudication in the affected joint, of moderate 
intensity, without significant alteration of the cardio-
respiratory frequency, according to the physiological 
patterns for the species [6,11].
A homogeneous stem cell culture was obtained 
from the 10th day of culture, with fusiform morphology, 
forming a monolayer on the 22nd day of culture. Flow 
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cytometry identified that mesenchymal stem cells were 
positive for CD34, CD73, CD90 and CD105 markers, 
and were negative for CD14, CD45 and CD79 markers 
(Figure 1). After the thawing of mesenchymal stem cells, 
after two years, 80% of viability was identified.
The culture medium of mesenchymal stem 
cells with a sterile hydrolyzed collagen sponge frag-
ment identified that the cells adhered to the sponge 
matrix after 10 days of incubation (Figure 2A and B) 
and the evaluation of the mean cell viability identified 
after removal of the fragment was 95%.
The histological evaluation of the same frag-
ment of sponge identified the presence of few mono-
nuclear cells adhered to the substrate of the same, with 
intact nucleus and loosely condensed chromatin. The 
cells were sparsely distributed between the pores of 
the sponge, isolated from each other.
An equine plasma of high platelet concentra-
tion and smaller in volume than whole blood was 
obtained. As the sample was sequentially centrifuged 
and the haematological and superficial fractions of 
the plasma were withdrawn, a product exclusively 
composed of concentrated platelets of 1.3 × 106/mm3, 
representing 82% of the initial platelet volume con-
centration, was obtained but in the volume of 0.4 mL, 
10 times lower than the initial one. 
After 60 days of treatment, it was observed that 
the lesions of the stem cells group presented formation 
of firm repair tissue, opaque staining, integrated with 
the adjacent cartilage and filling the failure almost in its 
entirety. Among the failures treated with PRP, on aver-
age, there was partial integration of the failure with the 
adjacent cartilage, with partial and symmetrical filling 
of the lesion and irregular and depressed lesion surface, 
with darkened, well circumscribed staining, surrounded 
by macroscopically healthy hyaline cartilage. The lesions 
treated with hemostatic sponge of hydrolyzed collagen 
presented, on average, partial filling of the lesion, uneven 
articular surface and reddish coloration (Figure 3A and B).
Histopathological differences (P < 0.05) were 
observed between the lesions treated with xenogenic 
mesenchymal stem cells and the other treatments. In 
the MSC group there was an average predominance 
of the presence of hyaline cartilage and a smooth 
cartilaginous surface in the lesions evaluated. In the 
lesions of the Platelet Rich Plasma and Control groups, 
the average prevalence of fibrocartilage was observed 
in relation to the hyaline cartilage, with an irregular 
and depressed articular surface (Figure 3C and D). No 
differences (P < 0.05) were observed between the le-
sions treated with xenogenic platelet rich plasma and 
hemostatic sponge of hydrolyzed collagen.
The osteochondral lesions of all treatment 
groups showed regenerated, subchondral bone charac-
terized by the presence of mature lamellar bone, com-
posed of osteocytes and the organization of trabecular 
bone tissue without the presence of osteoblasts.
It was not identified histopathological charac-
teristics of inflammatory activity and necrosis in none 
of the treated osteochondral failures.
Figure 1. Flow cytometry of mesenchymal stem cells in the fourth passage, derived from the dental pulp of agoutis (Dasyprocta primnolopha). 
A- Cells of fibroblastóid morphology and basophilic cytoplasm [Giemsa, Barra= 100 μm]. B, C, D- Negative expression for hematopoietic 
markers. E, F, G, H- Positive expression for markers commonly used for mesenchymal stem cell cultures.
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Figure 2. Interaction between mesenchymal stem cells and hemostatic sponge of hydrolyzed collagen. A- Cells fixed with 10% 
buffered paraformoldehyde and stained with May-Grunwald Giemsa, bordering the sponge fragment (*) [20x]. B- Histological 
section of the sponge after 10 days of incubation in culture with mesenchymal stem cells. The presence of a mononuclear cell 
(▲), of loose chromatin, adhered to the convolutions of the sponge matrix [Hematoxylin & Eosin 40x] is identified.
Figure 3. Macro and microscopic appearance of osteochondral lesions in femoral trochlea of goats after 60 days of treat-
ment. A- Lesion treated with collagen hemostatic sponge (*) presented partial filling of the lesion, with an uneven articular 
surface and reddish color. Lesion treated with xenogenic mesenchymal stem cells (●) presented complete lesion filling, with 
opaque staining repair tissue and integrated with the adjacent cartilage. Lesion treated with xenogenic platelet rich plasma 
(◘) presented partial lesion filling, with irregular and depressed surface, with darkened color, surrounded by macroscopically 
healthy hyaline cartilage. B- Joint surface with presence of hyaline cartilage (♦) arranged in irregular shape and surrounded 
by bone tissue (■) in the group treated with collagen hemostatic sponge. C- Joint surface with presence of hyaline cartilage 
(♦) in the group treated with xenogenic mesenchymal stem cells, characterized by the presence of chondrocytes (↑) arranged in 
isogenic groups in the cartilaginous matrix. D- Joint surface with presence of fibrocartilage in the group treated with xenogenic 
platelet rich plasma, characterized by thick collagen fibers (▲) between the rows of chondrocytes (↑). Hematoxylin-eosin 
staining [10x magnification].
DISCUSSION
The choice of goat as an animal model for the 
present study is due to the anatomical dimensions of 
the knee, similar to the dimensions of the human knee 
[5], allowing adequate exposure of the articular surface, 
favoring surgical manipulation.
The animals resumed spontaneous walking 
and showed appetite soon after anesthetic recovery. 
Similar results were described [7], using an equivalent 
anesthetic protocol, reiterating the effectiveness of the 
therapeutic pain management adopted in this study. The 
association between spinal local anesthesia associated 
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with morphine, probably contributed to a postopera-
tive period without clinical complications, associated 
with analgesic, antibiotic and anti-inflammatory use, 
as previously proposed [34].
The diameter chosen for the osteochondral 
lesions in this experiment was 4 mm in diameter, as 
recommended [15,34], according to them, lesions 
smaller than 3 mm may predispose to spontaneous 
repair by fibrocartilaginous tissue.
The use of hemostatic sponges such as scaffold 
for studies with repair of bone failures has already been 
described in previous research, both in humans and in 
animals [4,12], corroborating to justify the choice of 
this substrate for the model introduced. In addition, it 
is widely used in humans, possessing authorizations 
from governmental agencies of surveillance for com-
mercialization [32], and is then adopted as the gold 
standard in this study.
The in vitro biocompatibility assay between 
mesenchymal stem cells and a fragment of the hemo-
static sponge of hydrolyzed collagen demonstrated 
that there was no apparent cytotoxic effect on the 
cells, since the cultivation cells adhered to the frag-
ment were identified, with average viability of 95% 
identified by the trypan blue exclusion technique 
(Figure 2A and B). This technique is used to deter-
mine the number of viable cells in a cell suspension. 
It is based on the principle that viable cells (with 
intact cell membrane) are able to exclude trypan blue, 
which crosses the membrane, from its cytosol. While 
unviable cells (with compromised cell membrane), 
such as in advanced apoptotic state, are unable to 
exclude it [9].
Cells adhered to the substrate of the fragment 
were identified after histological processing, denoting 
that the substrate matrix provided an environment fa-
vorable to cell adhesion. Corroborates this observation, 
a contemporary study that inferred that cell-matrix 
interaction influences cell viability, which may induce 
apoptosis or not, depending on the chemical nature of 
the material used [37].  
However, it was not observed a high concen-
tration of cells adhered to the hydrolyzed collagen 
sponge, fact that remains incomprehensible by the 
authors of the present study. It is believed that the 
pore size of the sponge may have favored the low 
retention of cells in the substrate, since the cell vi-
ability observed in the biocompatibility assay was 
95%. Previous studies contribute to this hypothesis 
by indicating that the pore size and pore intercon-
nectivity of a scaffold is a determinant factor for 
cell fixation, and should be compatible with the 
dimensions of the cell population used [23,29]. 
However, it was not performed evaluation of the 
hemostatic sponge of hydrolyzed collagen by scan-
ning electron microscopy, and it was not possible 
to infer precisely the interference of the physical 
structure of the scaffold on the cellular retention. 
Complementary studies are needed to conduct this 
analysis, in addition to the reduction test of the 
bromide test 3- [4,5-dimethylthiazol-2-yl] -2,5-di-
phenyltetrazolium (MTT) to blue of formazan, as 
proposed in contemporary studies [1,13].
In the in vitro biocompatibility study, it was 
evident the alteration of the cellular morphology of 
MSC. This effect was expected, since MSCs are ad-
herent mononuclear cells that assume fibroblastoid or 
fusiform morphology only when on a regular surface 
in the culture medium like in controlled incubation 
conditions [3]. Since the porous surface of the ir-
regular hemostatic sponge, MSC was visualized in 
mononuclear oval form.
After 60 days of observation, they were not 
evident macro or microscopic traces of the hemostatic 
sponge inside the osteochondral failures evaluated, 
corroborating with previous reports of biocompatibility 
and resorption in vivo [30].
It was not observed macroscopic and histo-
pathological evidence of inflammatory process on the 
surface and in the internal portion of the osteochondral 
lesions analyzed in this study. Such observations are of 
great importance, since graft-versus-host disease syn-
drome is an acute or hyperacute condition, responsible 
for the low therapeutic efficacy with transplantation 
of cells or grafts in humans [35]. According to these 
authors, approximately 40% to 50% of human patients 
undergoing bone marrow transplantation develop such 
a clinical condition [17].
It was expected absence of response macro 
and histopathological of rejection in osteochondral 
failures treated with hydrolyzed collagen sponge 
of porcine origin, since it is already commercially 
used in humans, as observed in contemporary stud-
ies [32,33].
However, the inexistence of tissue evidence of 
rejection in the osteochondral failures treated with PRP 
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and MSC is considered a positive preliminary datum, 
although it can not be inferred that this result is repro-
duced in other animals, under other methodological 
conditions of study.
In the present study, osteochondral failures 
treated with PRP and hydrolyzed collagen sponge in-
duced formation of fibrocartilaginous cartilage, without 
macro and microscopic evidence of degeneration or 
necrosis. A similar result was obtained [7], using PRP 
in osteochondral lesion of sheep knee, in which there 
was predominance of fibrocartilage on the articular sur-
face. Paracrine factors of the local microenvironment of 
the osteochondral failure are possibly responsible for 
the formation of fibrocartilaginous tissue or inhibition 
of normal cartilage formation [34]. The greater occur-
rence of the fibrocartilaginous surface in the Platelet 
Rich Plasma and Control groups contributed to the 
commitment in the filling of the lesion, observed in the 
macroscopic evaluation, where it was verified integra-
tion and partial filling of the failure, in an irregular and 
depressed form, with coloration varying darkened to 
reddish, respectively.
The PRP has been used for about 20 years 
with the objective of accelerating the healing and re-
generation of bone resulting from surgical procedures 
in humans. The plasma has a high concentration of 
platelets in a reduced plasma volume, besides growth 
factors that behave like molecules of cellular adhe-
sion in the processes of epithelial migration, osteo-
induction and in the formation of bone matrix in the 
connective tissue. Due to the high concentration of 
growth factors that stimulate cell migration and tissue 
remodeling, it is believed that the xenogeneic use of 
PRP may be responsible for the greater formation 
of fibrocartilage, as suggested in previous studies 
[28,38]. However, as there was no histopathological 
inflammatory response, new studies using immuno-
histochemical techniques to elucidate the influence 
of xenogenic PRP on osteocartilaginous tissue are 
suggested.
The effect of MSC on bone tissue repair had 
been described in contemporary studies [2,25,33]. Ac-
cording to these authors, MSCs are multipotent somatic 
progenitor cells, capable of originating mesodermal 
and not mesodermal tissues. The differentiation of 
these cells in vitro into osteoblasts has been induced 
in several previous studies [3,8].
The xenogeneic MSCs that remained adhered 
to the hemostatic sponge induced greater formation 
of hyaline cartilage (P < 0.05) when compared to the 
other treatments. In addition, the osteochondral failures 
treated with these cells did not present macro and his-
topathological evidence of degeneration, inflammation 
and/or tissue necrosis.
The MSCs do not express significant levels 
of the class II histocompatibility complex and do not 
have costimulatory molecules, such as B7-1 and B7-2, 
theoretically exhibiting a low rejection response [36]. 
However, MSCs express MHC class I and some lineag-
es express binding CD40 and CD40 molecules, which 
may in some circumstances be identified by Toll Like 
Receptors which in turn could induce immunogenic 
activation [22]. Given such controversies, preclinical 
studies, as presented here, are of great relevance in 
assessing the clinical and histopathological response 
of MSCs in osteochondral failures.
It was considered the maintenance of joint sur-
face integrity and neoformation of hyaline cartilage in 
the knee lesions of the animals treated in this study very 
satisfactory, since in the repair of osteochondral lesions it 
is expected that there is no significant recruitment of os-
teocartilaginous tissue, so as not to inducing fibrocartilage 
formation, which could compromise joint function [38].
In this study, a presence of mature subchondral 
bone was evidenced in all the treatments performed, 
demonstrating that there was a satisfactory repair of 
the deep part of the osteochondral lesion against the 
treatments used, without evidence of deleterious effect 
in the cartilaginous surface.
CONCLUSIONS
Mesenchymal stem cell xenotransplant in-
duced hyaline cartilage formation and did not promote 
histopathological evidence of rejection in osteochon-
dral lesions of goat knees.
The sterile hemostatic sponge of hydrolyzed 
collagen presented biocompatibility with the xenoge-
neic MSCs, preserving its viability.
The treatments with PRP and hemostatic 
sponge of hydrolyzed collagen induced greater forma-
tion of fibrocartilaginous cartilaginous surface in the 
osteochondral failures. Macroscopically, it was evident 
filling of the inferior lesion for other treatments and 
discrepant coloring of normal cartilage.
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